{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:55:36Z","timestamp":1762977336770,"version":"3.45.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["MLP138"],"award-info":[{"award-number":["MLP138"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.xpro.2021.101027","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T07:57:34Z","timestamp":1639468654000},"page":"101027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subcutaneous amyloidoma models for screening potential anti-fibrillating agents in\u00a0vivo"],"prefix":"10.1016","volume":"2","author":[{"given":"Debajyoti","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avishek","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujay Krishna","family":"Maity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhrangsu","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-8695","authenticated-orcid":false,"given":"Partha","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2021.101027_bib1","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1021\/bi034868o","article-title":"Partially folded intermediates in insulin fibrillation","volume":"42","author":"Ahmad","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.xpro.2021.101027_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/1932296817747292","article-title":"Insulin concentration in vials randomly purchased in pharmacies in the United States: considerable loss in the cold supply chain","volume":"12","author":"Carter","year":"2018","journal-title":"J.\u00a0Diabetes Sci. Technol."},{"key":"10.1016\/j.xpro.2021.101027_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3892\/etm.2014.1772","article-title":"Generating local amyloidosis in mice by the subcutaneous injection of human insulin amyloid fibrils","volume":"8","author":"Chinisaz","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.xpro.2021.101027_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/13506129.2013.876984","article-title":"Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration","volume":"21","author":"D\u2019Souza","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.xpro.2021.101027_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JBO.26.4.043007","article-title":"Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance","volume":"26","author":"Delbeck","year":"2021","journal-title":"J.\u00a0Biomed. Opt."},{"key":"10.1016\/j.xpro.2021.101027_bib6","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/endo.143.6.8859","article-title":"Comparison of insulin secretory function in two mouse models with different susceptibility to \u03b2-cell failure","volume":"143","author":"Kooptiwut","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.xpro.2021.101027_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-219491","article-title":"Isolated insulin-derived amyloidoma of the breast","volume":"2017","author":"Mayhew","year":"2017","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.xpro.2021.101027_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8906","article-title":"Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements","volume":"6","author":"Morley","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2021.101027_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102573","article-title":"Prion-derived tetrapeptide stabilizes thermolabile insulin via conformational trapping","volume":"24","author":"Mukherjee","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xpro.2021.101027_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjmed.2013.10.029","article-title":"Insulin-derived amyloidosis and poor glycemic control: a case series","volume":"127","author":"Nagase","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.xpro.2021.101027_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0140-6736(09)60041-6","article-title":"The insulin ball","volume":"373","author":"Nagase","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.xpro.2021.101027_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/db18-0846","article-title":"Extreme adhesion activity of amyloid fibrils induces subcutaneous insulin resistance","volume":"68","author":"Nakamura","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.xpro.2021.101027_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/13506129.2016.1179183","article-title":"Insulin amyloid at injection sites of patients with diabetes","author":"Nilsson","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.xpro.2021.101027_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/193229681200600209","article-title":"Intrinsic fibrillation of fast-acting insulin analogs","volume":"6","author":"Woods","year":"2012","journal-title":"J.\u00a0Diabetes Sci. Technol."},{"key":"10.1016\/j.xpro.2021.101027_bib15","first-page":"1","article-title":"Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPAR\u03b3","volume":"9","author":"Zheng","year":"2014","journal-title":"PLoS ONE"}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166721007334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166721007334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:51:00Z","timestamp":1762977060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166721007334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666166721007334"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2021.101027","relation":{},"ISSN":["2666-1667"],"issn-type":[{"type":"print","value":"2666-1667"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous amyloidoma models for screening potential anti-fibrillating agents in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2021.101027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2021.102573","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101027"}}